Ling Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ling Wang has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Yaobin Wu
Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, Guangdong Provincial Key Laboratory of Digital Medicine and Biomechanics, Department of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
16 shared publications Liu Yu
Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, Guangdong Provincial Key Laboratory of Digital Medicine and Biomechanics, Department of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
10 shared publicationsJie Xu
Biomaterials Research Center School of Biomedical Engineering Southern Medical University Guangzhou 510515 China
8 shared publicationsSitian Liu
Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, Guangdong Provincial Key Laboratory of Digital Medicine and Biomechanics, Department of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
7 shared publicationsTing Li
Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, Guangdong Provincial Key Laboratory of Digital Medicine and Biomechanics, Department of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
7 shared publications- Wenhua Huang
Guangdong Engineering Research Center for Translation of Medical 3D Printing Application, Guangdong Provincial Key Laboratory of Medical Biomechanics, National Key Discipline of Human Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
7 shared publications
Latest Publications
- Open Access
- 6 December 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1)
Laminin-conjugated aligned nanofiber yarns for topographical and biochemical guidance of neurite outgrowth and branching regulation
Aligned nanofiber scaffolds have shown great promise in promoting neurite orientation and elongation, making them a key design strategy in peripheral nerve
- 6 December 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1)
Open AccessLaminin-conjugated aligned nanofiber yarns for topographical and biochemical guidance of neurite outgrowth and branching regulation
Aligned nanofiber scaffolds have shown great promise in promoting neurite orientation and elongation, making them a key design strategy in peripheral nerve
- 10 September 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 205, 141-163
Progress in engineering functional cardiac tissues from iPSC-derived cardiomyocytes: advances in construction and applications
- 10 September 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 205, 141-163
Progress in engineering functional cardiac tissues from iPSC-derived cardiomyocytes: advances in construction and applications
Engineering Cardiobundles with Dynamic Microenvironmental Control as Advanced Cardiac Modeling for Heart‐on‐a‐Chip
Advancing cardioprotective therapies requires physiologically relevant preclinical models, yet conventional approaches—including 2D cell cultures, 3D spheroids, and animal models—fail to fully recapitulate the structural complexity and dynamic microenvironment of native cardiac tissue, often facing species‐specific discrepancies and ethical concerns. Organ‐on‐a‐chip (OoC) technology, a microfluidic‐based biomimetic system, offers real‐time organ‐level physiology and disease progression monitoring. In this study, a heart‐on‐a‐chip (HoC) platform is developed by integrating cardiobundles—engineered 3D cardiac tissues—with microfluidic technology. Using a fibrinogen‐Matrigel hydrogel system, aligned cardiobundles are fabricated that mimic the native myocardial architecture and function. The HoC system demonstrates enhanced cardiomyocyte differentiation, intercellular connectivity, calcium handling, and contractility. Furthermore, the effects of oxygen and nutrient circulation, as well as dynamic microenvironmental conditions, are systematically assessed on cardiobundle performance, highlighting the platform's physiological relevance. This biomimetic HoC represents a promising tool for drug screening, disease modeling, and personalised medicine, offering a physiologically relevant alternative to traditional cardiac models in preclinical research.
Engineering Cardiobundles with Dynamic Microenvironmental Control as Advanced Cardiac Modeling for Heart‐on‐a‐Chip
Advancing cardioprotective therapies requires physiologically relevant preclinical models, yet conventional approaches—including 2D cell cultures, 3D spheroids, and animal models—fail to fully recapitulate the structural complexity and dynamic microenvironment of native cardiac tissue, often facing species‐specific discrepancies and ethical concerns. Organ‐on‐a‐chip (OoC) technology, a microfluidic‐based biomimetic system, offers real‐time organ‐level physiology and disease progression monitoring. In this study, a heart‐on‐a‐chip (HoC) platform is developed by integrating cardiobundles—engineered 3D cardiac tissues—with microfluidic technology. Using a fibrinogen‐Matrigel hydrogel system, aligned cardiobundles are fabricated that mimic the native myocardial architecture and function. The HoC system demonstrates enhanced cardiomyocyte differentiation, intercellular connectivity, calcium handling, and contractility. Furthermore, the effects of oxygen and nutrient circulation, as well as dynamic microenvironmental conditions, are systematically assessed on cardiobundle performance, highlighting the platform's physiological relevance. This biomimetic HoC represents a promising tool for drug screening, disease modeling, and personalised medicine, offering a physiologically relevant alternative to traditional cardiac models in preclinical research.
- 5 May 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (42)
A Photocurable Elastic Polyester‐Based Janus Bio‐Adhesive for Press‐Induced In Situ Wound Closure
Tissue bio‐adhesives are a promising solution for wound closure. However, most bio‐adhesives exhibit a significant decrease in adhesion strength in dynamic environments, making it challenging to provide adequate mechanical properties and personalized morphology that match native tissues. To address these limitations, this study presents an elastic polyester (POMCN) developed by blending poly (octamethylene maleate (acid anhydride) citrate) (POMC) precursor and acrylic acid N‐hydroxy succinimide (AA‐NHS) esters, followed by ultraviolet (UV) induced crosslinking. POMCN possesses in situ photopolymerization capability, enabling covalent crosslinking with amine groups to maintain long‐term and robust adhesion. To accommodate various wound types, both the mechanical and adhesive properties of POMCN can be tuned by adjusting the AA‐NHS content. Subsequently, a water‐soluble starch film is introduced to facilitate POMCN application, enhancing tissue adhesion and ensuring better conformity to wound morphology. The in vivo animal model experiments demonstrated that the POMCN patch significantly improved wound closure, promoted healing, and effectively prevented postsurgical adhesions. Collectively, the application of an elastic polyester patch with an in situ photopolymerization presents an efficient strategy route for dynamic wound healing, offering immense potential for improving clinical outcomes and restoring tissue integrity.
- 5 May 2025
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (42)
A Photocurable Elastic Polyester‐Based Janus Bio‐Adhesive for Press‐Induced In Situ Wound Closure
Tissue bio‐adhesives are a promising solution for wound closure. However, most bio‐adhesives exhibit a significant decrease in adhesion strength in dynamic environments, making it challenging to provide adequate mechanical properties and personalized morphology that match native tissues. To address these limitations, this study presents an elastic polyester (POMCN) developed by blending poly (octamethylene maleate (acid anhydride) citrate) (POMC) precursor and acrylic acid N‐hydroxy succinimide (AA‐NHS) esters, followed by ultraviolet (UV) induced crosslinking. POMCN possesses in situ photopolymerization capability, enabling covalent crosslinking with amine groups to maintain long‐term and robust adhesion. To accommodate various wound types, both the mechanical and adhesive properties of POMCN can be tuned by adjusting the AA‐NHS content. Subsequently, a water‐soluble starch film is introduced to facilitate POMCN application, enhancing tissue adhesion and ensuring better conformity to wound morphology. The in vivo animal model experiments demonstrated that the POMCN patch significantly improved wound closure, promoted healing, and effectively prevented postsurgical adhesions. Collectively, the application of an elastic polyester patch with an in situ photopolymerization presents an efficient strategy route for dynamic wound healing, offering immense potential for improving clinical outcomes and restoring tissue integrity.
- 26 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402074
Coaxial Electrospun Nanofibrous Membranes as Dual‐Functional Biomimetic Tendon Sheath for Tendon Repair and Anti‐Peritendinous Adhesion
Tendon injuries often exhibit limited healing capacity, frequently complicated by peritendinous adhesion, posing a substantial challenge in clinical tendon repair. Although present biomaterial‐based membranes offer a promising strategy for tendon treatment, their clinical application is hindered by inflammation‐induced adhesion. Herein, this study presents a dual‐functional biomimetic tendon sheath based on a coaxial electrospun nanofibrous membrane for enhancing tendon repair and simultaneously preventing peritendinous adhesion. This nanofibrous membrane is fabricated using a coaxial electrospinning method, encapsulating celecoxib‐loaded polycaprolactone (PCL) within gelatin methacryloyl (GelMA) shell. Both in vitro and in vivo analysis results demonstrated that such coaxial biomimetic tendon sheath enhanced tenogenic differentiation of tendon stem/progenitor cells (TSPCs) due to nanofibrous GelMA shell providing a suitable microenvironment surface. Simultaneously, the sustained release of celecoxib (CEL) from the core is able to significantly decrease the expression of inflammatory cytokines. Notably, in vivo assessments in animal models with patellar tendon defects revealed significant reductions in peritendinous adhesion, leading to further enhancement in tendon repair. These results underscore the potential of the coaxial nanofibrous membrane as a dual‐functional biomimetic tendon sheath, offering a promising avenue for the long‐term management of tendon injuries.
- 26 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402074
Coaxial Electrospun Nanofibrous Membranes as Dual‐Functional Biomimetic Tendon Sheath for Tendon Repair and Anti‐Peritendinous Adhesion
Tendon injuries often exhibit limited healing capacity, frequently complicated by peritendinous adhesion, posing a substantial challenge in clinical tendon repair. Although present biomaterial‐based membranes offer a promising strategy for tendon treatment, their clinical application is hindered by inflammation‐induced adhesion. Herein, this study presents a dual‐functional biomimetic tendon sheath based on a coaxial electrospun nanofibrous membrane for enhancing tendon repair and simultaneously preventing peritendinous adhesion. This nanofibrous membrane is fabricated using a coaxial electrospinning method, encapsulating celecoxib‐loaded polycaprolactone (PCL) within gelatin methacryloyl (GelMA) shell. Both in vitro and in vivo analysis results demonstrated that such coaxial biomimetic tendon sheath enhanced tenogenic differentiation of tendon stem/progenitor cells (TSPCs) due to nanofibrous GelMA shell providing a suitable microenvironment surface. Simultaneously, the sustained release of celecoxib (CEL) from the core is able to significantly decrease the expression of inflammatory cytokines. Notably, in vivo assessments in animal models with patellar tendon defects revealed significant reductions in peritendinous adhesion, leading to further enhancement in tendon repair. These results underscore the potential of the coaxial nanofibrous membrane as a dual‐functional biomimetic tendon sheath, offering a promising avenue for the long‐term management of tendon injuries.
- 26 June 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (48)
A Sprayable Janus Hydrogel as an Effective Bioadhesive for Gastrointestinal Perforation Repair
Advancements in hydrogel bioadhesives for sealing gastrointestinal perforations (GP) face challenges due to weak mechanical properties, causing leakage, especially on uneven wound surfaces. Herein, a Janus hydrogel is introduced featuring a two‐step cross‐linking process, designed to serve as an efficient bioadhesive using a sprayable method. This Janus hydrogel formulation is achieved by modifying a photocurable hyaluronic acid hydrogel with dopamine (DA) and phenylboronic acid (PBA) groups, enabling reversible boronate ester bonds. These dynamic cross‐linking bonds facilitate shear‐thinning and self‐healing abilities, ensuring secure adhesion to complex wounds. A subsequent photocurable irreversible cross‐linking stage results in the formation of a hydrogel barrier with asymmetric adhesive properties, imparting inherent mechanical strength for postoperative anti‐adhesion. To enhance the clinical practicality of this hydrogel, an integrated sprayer device is further developed, enabling the efficient delivery of hydrogel at any angle and over long distances under minimally invasive conditions. Therefore, the HADP hydrogel, integrated with the sprayer device, successfully addressed the limitations associated with hydrogel bioadhesives in clinical applications concerning angles and terrains. This integrated approach presents a compelling solution for repairing gastrointestinal perforations in clinical settings. Moreover, it demonstrates significant potential for diverse applications in repairing complex wound surfaces.
- 26 June 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (48)
A Sprayable Janus Hydrogel as an Effective Bioadhesive for Gastrointestinal Perforation Repair
Advancements in hydrogel bioadhesives for sealing gastrointestinal perforations (GP) face challenges due to weak mechanical properties, causing leakage, especially on uneven wound surfaces. Herein, a Janus hydrogel is introduced featuring a two‐step cross‐linking process, designed to serve as an efficient bioadhesive using a sprayable method. This Janus hydrogel formulation is achieved by modifying a photocurable hyaluronic acid hydrogel with dopamine (DA) and phenylboronic acid (PBA) groups, enabling reversible boronate ester bonds. These dynamic cross‐linking bonds facilitate shear‐thinning and self‐healing abilities, ensuring secure adhesion to complex wounds. A subsequent photocurable irreversible cross‐linking stage results in the formation of a hydrogel barrier with asymmetric adhesive properties, imparting inherent mechanical strength for postoperative anti‐adhesion. To enhance the clinical practicality of this hydrogel, an integrated sprayer device is further developed, enabling the efficient delivery of hydrogel at any angle and over long distances under minimally invasive conditions. Therefore, the HADP hydrogel, integrated with the sprayer device, successfully addressed the limitations associated with hydrogel bioadhesives in clinical applications concerning angles and terrains. This integrated approach presents a compelling solution for repairing gastrointestinal perforations in clinical settings. Moreover, it demonstrates significant potential for diverse applications in repairing complex wound surfaces.
- 4 June 2024
- Published by Springer Nature in Advanced Fiber Materials
- Vol. 6 (5) , 1521-1540
3D Printing-Electrospinning Hybrid Nanofibrous Scaffold as LEGO-Like Bricks for Modular Assembling Skeletal Muscle-on-a-Chip Functional Platform
- 4 June 2024
- Published by Springer Nature in Advanced Fiber Materials
- Vol. 6 (5) , 1521-1540
3D Printing-Electrospinning Hybrid Nanofibrous Scaffold as LEGO-Like Bricks for Modular Assembling Skeletal Muscle-on-a-Chip Functional Platform
- Open Access
- 5 May 2024
- Published by Wiley in Advanced Science
- Vol. 11 (26) , 2403227
Logic‐Based Strategy for Spatiotemporal Release of Dual Extracellular Vesicles in Osteoarthritis Treatment
To effectively treat osteoarthritis (OA), the existing inflammation must be reduced before the cartilage damage can be repaired; this cannot be achieved with a single type of extracellular vesicles (EVs). Here, a hydrogel complex with logic‐gates function is proposed that can spatiotemporally controlled release two types of EVs: interleukin 10 (IL‐10)+ EVs to promote M2 polarization of macrophage, and SRY‐box transcription factor 9 (SOX9)+ EVs to increase cartilage matrix synthesis. Following dose‐of‐action screening, the dual EVs are loaded into a matrix metalloporoteinase 13 (MMP13)‐sensitive self‐assembled peptide hydrogel (KM13E) and polyethylene glycol diacrylate/gelatin methacryloyl‐hydrogel microspheres (PGE), respectively. These materials are mixed to form a “microspheres‐in‐gel” KM13E@PGE system. In vitro, KM13E@PGE abruptly released IL‐10+ EVs after 3 days and slowly released SOX9+ EVs for more than 30 days. In vivo, KM13E@PGE increased the CD206+ M2 macrophage proportion in the synovial tissue and decreased the tumor necrosis factor‐α and IL‐1β levels. The aggrecan and SOX9 expressions in the cartilage tissues are significantly elevated following inflammation subsidence. This performance is not achieved using anti‐inflammatory or cartilage repair therapy alone. The present study provides an injectable, integrated delivery system with spatiotemporal control release of dual EVs, and may inspire logic‐gates strategies for OA treatment.
- 5 May 2024
- Published by Wiley in Advanced Science
- Vol. 11 (26) , 2403227
Open AccessLogic‐Based Strategy for Spatiotemporal Release of Dual Extracellular Vesicles in Osteoarthritis Treatment
To effectively treat osteoarthritis (OA), the existing inflammation must be reduced before the cartilage damage can be repaired; this cannot be achieved with a single type of extracellular vesicles (EVs). Here, a hydrogel complex with logic‐gates function is proposed that can spatiotemporally controlled release two types of EVs: interleukin 10 (IL‐10)+ EVs to promote M2 polarization of macrophage, and SRY‐box transcription factor 9 (SOX9)+ EVs to increase cartilage matrix synthesis. Following dose‐of‐action screening, the dual EVs are loaded into a matrix metalloporoteinase 13 (MMP13)‐sensitive self‐assembled peptide hydrogel (KM13E) and polyethylene glycol diacrylate/gelatin methacryloyl‐hydrogel microspheres (PGE), respectively. These materials are mixed to form a “microspheres‐in‐gel” KM13E@PGE system. In vitro, KM13E@PGE abruptly released IL‐10+ EVs after 3 days and slowly released SOX9+ EVs for more than 30 days. In vivo, KM13E@PGE increased the CD206+ M2 macrophage proportion in the synovial tissue and decreased the tumor necrosis factor‐α and IL‐1β levels. The aggrecan and SOX9 expressions in the cartilage tissues are significantly elevated following inflammation subsidence. This performance is not achieved using anti‐inflammatory or cartilage repair therapy alone. The present study provides an injectable, integrated delivery system with spatiotemporal control release of dual EVs, and may inspire logic‐gates strategies for OA treatment.
- 9 April 2024
- Published by Wiley in Small Methods
- Vol. 8 (9) , 2301754
Electrospun Aligned Nanofiber Yarns Constructed Biomimetic M‐Type Interface Integrated into Precise Co‐Culture System as Muscle‐Tendon Junction‐on‐a‐Chip for Drug Development
The incorporation of engineered muscle‐tendon junction (MTJ) with organ‐on‐a‐chip technology provides promising in vitro models for the understanding of cell‐cell interaction at the interface between muscle and tendon tissues. However, developing engineered MTJ tissue with biomimetic anatomical interface structure remains challenging, and the precise co‐culture of engineered interface tissue is further regarded as a remarkable obstacle. Herein, an interwoven waving approach is presented to develop engineered MTJ tissue with a biomimetic “M‐type” interface structure, and further integrated into a precise co‐culture microfluidic device for functional MTJ‐on‐a‐chip fabrication. These multiscale MTJ scaffolds based on electrospun nanofiber yarns enabled 3D cellular alignment and differentiation, and the “M‐type” structure led to cellular organization and interaction at the interface zone. Crucially, a compartmentalized co‐culture system is integrated into an MTJ‐on‐a‐chip device for the precise co‐culture of muscle and tendon zones using their medium at the same time. Such an MTJ‐on‐a‐chip device is further served for drug‐associated MTJ toxic or protective efficacy investigations. These results highlight that these interwoven nanofibrous scaffolds with biomimetic “M‐type” interface are beneficial for engineered MTJ tissue development, and MTJ‐on‐a‐chip with precise co‐culture system indicated their promising potential as in vitro musculoskeletal models for drug development and biological mechanism studies.
- 9 April 2024
- Published by Wiley in Small Methods
- Vol. 8 (9) , 2301754
Electrospun Aligned Nanofiber Yarns Constructed Biomimetic M‐Type Interface Integrated into Precise Co‐Culture System as Muscle‐Tendon Junction‐on‐a‐Chip for Drug Development
The incorporation of engineered muscle‐tendon junction (MTJ) with organ‐on‐a‐chip technology provides promising in vitro models for the understanding of cell‐cell interaction at the interface between muscle and tendon tissues. However, developing engineered MTJ tissue with biomimetic anatomical interface structure remains challenging, and the precise co‐culture of engineered interface tissue is further regarded as a remarkable obstacle. Herein, an interwoven waving approach is presented to develop engineered MTJ tissue with a biomimetic “M‐type” interface structure, and further integrated into a precise co‐culture microfluidic device for functional MTJ‐on‐a‐chip fabrication. These multiscale MTJ scaffolds based on electrospun nanofiber yarns enabled 3D cellular alignment and differentiation, and the “M‐type” structure led to cellular organization and interaction at the interface zone. Crucially, a compartmentalized co‐culture system is integrated into an MTJ‐on‐a‐chip device for the precise co‐culture of muscle and tendon zones using their medium at the same time. Such an MTJ‐on‐a‐chip device is further served for drug‐associated MTJ toxic or protective efficacy investigations. These results highlight that these interwoven nanofibrous scaffolds with biomimetic “M‐type” interface are beneficial for engineered MTJ tissue development, and MTJ‐on‐a‐chip with precise co‐culture system indicated their promising potential as in vitro musculoskeletal models for drug development and biological mechanism studies.
- Open Access
- 4 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (31) , eadh1753
Injectable photocurable Janus hydrogel delivering hiPSC cardiomyocyte-derived exosome for post–heart surgery adhesion reduction
Postsurgical pericardial adhesions pose increased risks of sequelae, prolonged reoperation time, and reduced visibility in the surgical field. Here, we introduce an injectable Janus hydrogel, which exhibits asymmetric adhesiveness properties after photocrosslinking, sustained delivering induced pluripotent stem cell–derived cardiomyocyte exosomes (iCM-EXOs) for post–heart surgery adhesion reduction. Our findings reveal that iCM-EXOs effectively attenuate oxidative stress in hydrogen peroxide–treated primary cardiomyocytes by inhibiting the activation of the transcription factor nuclear factor erythroid 2–related factor 2. Notably, in rat cardiac postsurgery models, the Janus hydrogels loaded with iCM-EXOs demonstrate dual functionality, acting as antioxidants and antipericardial adhesion agents. These hydrogels effectively protect iCM-EXOs from GATA 6+ cavity macrophage clearance by inhibiting the recruitment of macrophages from the thoracic cavity. These results highlight the promising potential of iCM-EXO–laden Janus hydrogels for clinical safety and efficacy validation in trials involving heart surgery patients, with the ultimate goal of routine administration during open-heart surgeries.
- 4 August 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (31) , eadh1753
Open AccessInjectable photocurable Janus hydrogel delivering hiPSC cardiomyocyte-derived exosome for post–heart surgery adhesion reduction
Postsurgical pericardial adhesions pose increased risks of sequelae, prolonged reoperation time, and reduced visibility in the surgical field. Here, we introduce an injectable Janus hydrogel, which exhibits asymmetric adhesiveness properties after photocrosslinking, sustained delivering induced pluripotent stem cell–derived cardiomyocyte exosomes (iCM-EXOs) for post–heart surgery adhesion reduction. Our findings reveal that iCM-EXOs effectively attenuate oxidative stress in hydrogen peroxide–treated primary cardiomyocytes by inhibiting the activation of the transcription factor nuclear factor erythroid 2–related factor 2. Notably, in rat cardiac postsurgery models, the Janus hydrogels loaded with iCM-EXOs demonstrate dual functionality, acting as antioxidants and antipericardial adhesion agents. These hydrogels effectively protect iCM-EXOs from GATA 6+ cavity macrophage clearance by inhibiting the recruitment of macrophages from the thoracic cavity. These results highlight the promising potential of iCM-EXO–laden Janus hydrogels for clinical safety and efficacy validation in trials involving heart surgery patients, with the ultimate goal of routine administration during open-heart surgeries.